UTSW researchers neutralize genetic risk factor found in 50 to 80 percent of human cases
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.
Apolipoprotein E (ApoE) is a protein that carries fatty substances called lipids and cholesterol around the brain and plays an important role in repair mechanisms. There are three major forms of ApoE (i.e., ApoE2, ApoE3, and ApoE4); individuals who carry ApoE4 are up to 10 times more likely to develop Alzheimer’s than those with ApoE2 and ApoE3 forms. ApoE4 promotes accumulation of the b-amyloid protein that causes the characteristic plaques seen in the brains of Alzheimer’s patients.
UT Southwestern molecular biologist and Alzheimer’s expert Dr. Joachim Herz, lead author of the study, which was published in the November issue of eLife said the goal of his team is to prevent the disease from ever manifesting. Late-onset Alzheimer’s generally is diagnosed about age 65 and is the most common cause of dementia in the elderly. “If we can negate the ApoE4 process early, we may be able to prevent late-onset Alzheimer’s altogether for many people so that they will never get sick,” Dr. Herz said.
ApoE4 has been shown to suppress and trap synaptic receptors within intracellular vesicles. However, how the ApoE4 gets trapped has remained a mystery until now. According to Dr. Herz, ApoE4 is the root cause of a “traffic jam” inside the cells that take up ApoE4 and this is associated with reduced recycling of intracellular endosomal transport vesicles. UTSW researchers found that lowering the pH of these endosomes, i.e., by making them more acidic, cleared the traffic jam: The scientists were able to completely reverse the ApoE4-induced recycling block in mice through pharmacological and genetic inhibition of the NHE6 protein, which acts to make the endosomal vesicles less acidic.
These findings suggest a novel potential therapeutic approach for the prevention of late-onset Alzheimer’s disease, Dr. Herz said. The vesicle traffic jam due to the selective loss of solubility of ApoE4 likely is the earliest mechanism at which the protein negatively affects nerve cells, Dr. Herz said.
Most Alzheimer’s research has focused on halting the formation of amyloid and tau protein aggregates once they exist in the brain and degeneration has already begun. “Our approach in this study was to stop the overall degeneration process earlier; that is, before the formation of these aggregates,” Dr. Herz said.
The next step is to develop tailor-made, small molecule inhibitors that can enter the brain efficiently and selectively block NHE6, he added.
“The beauty of NHE inhibitors is that these are small molecules that can be produced inexpensively and thus made widely available, in contrast to the more elaborate antibody-based therapies that are currently being evaluated in clinical trials. A simple pill could someday neutralize the risk of late-onset Alzheimer’s disease just as readily available statins are able to reduce the risk of cardiovascular disease,” Dr. Herz said.
Learn more: Research suggests path to vaccine or drug for late-onset Alzheimer’s
The Latest on: Late-onset Alzheimer’s
[google_news title=”” keyword=”late-onset Alzheimer’s” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Late-onset Alzheimer’s
- Florida clinic plans to treat 10,000 Alzheimer’s patients a year. Look at what’s comingon April 25, 2024 at 7:20 am
Roskamp’s planned Bishop-Parker Clinic will enable Roskamp to assess, treat and support more than 10,000 patients a year, Wendy Deming, CEO of the Bishop-Parker Foundation, said Wednesday.
- Havasu defendant, 90, will receive mental health evaluation to determine competencyon April 24, 2024 at 4:12 pm
An elderly Lake Havasu City man could receive a mental health evaluation this month, as he awaits trial on multiple felonies stemming from an alleged pursuit last month by law ...
- The number of people with Alzheimer’s disease in their 40s or 50s could be underestimatedon April 24, 2024 at 8:33 am
Could you develop this disease at such an early age? Your family history could be telling, medical professionals say.
- Alzheimer’s Disease Neurons Reenter Cell Cycle, Become Senescenton April 23, 2024 at 3:56 pm
Senescent cells displayed more proinflammatory, metabolically deregulated, and pathology-associated signatures ...
- Keto diet may help lower cholesterol, toxic proteins in Alzheimer’s diseaseon April 23, 2024 at 10:31 am
New research in rat models of Alzheimer's disease suggests that a ketogenic diet may help lower blood lipids and tau protein levels, improving Alzheimer's-like symptoms.
- Alzheimer's: I know I'm going to have early onset dementiaon April 20, 2024 at 11:04 pm
James Bexon was just 33 when he was told he had between 20 and 30 years before developing Alzheimer's. His father was diagnosed at 58, and in 2018 James took an NHS test which said he had a 99.9% ...
- A Study Has Revealed The Biggest Risk Factors For Getting Early Dementia, And Knowledge Is Poweron April 19, 2024 at 4:16 am
“An active daily exercise practice can have far-reaching benefits, which include enhanced neurocognitive function,” Fesharaki-Zadeh said, adding that physical activity can boost neurogenesis (the ...
- Vision changes could predict dementia 12 years before diagnosis, study sayson April 15, 2024 at 8:38 am
Scientists and medical professionals have emphasised the importance of early detection for Alzheimer's and dementia.
via Bing News